BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9744734)

  • 21. Coexistence of Brenner tumors with epithelial neoplasia.
    Azoury RS; Mansour ME; Sibai BM
    Gynecol Oncol; 1978 Dec; 6(6):546-64. PubMed ID: 220149
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ovarian tumors of low malignant potential (borderline ovarian tumors)].
    Luchian AM; Pricop M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):438-45. PubMed ID: 21870737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mature cystic teratoma of ovary with mucinous epithelial neoplasm and malignant mural nodule: a case report and review of the literature.
    Vernea F; Volodarsky-Perel A
    Int J Gynecol Pathol; 2015 Jan; 34(1):25-9. PubMed ID: 25473749
    [No Abstract]   [Full Text] [Related]  

  • 24. MDM2 Expression in Serous and Mucinous Epithelial Tumours of the Ovary.
    Abdelaal SE; Habib FM; El Din AA; Gabal SM; Hassan NS; Ibrahim NA
    Asian Pac J Cancer Prev; 2016; 17(7):3295-300. PubMed ID: 27509966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Borderline mixed epithelial tumor of the ovary].
    Osadchaia VV
    Arkh Patol; 1980; 42(10):56-8. PubMed ID: 7447744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis.
    Banet N; Kurman RJ
    Int J Gynecol Pathol; 2015 Jan; 34(1):3-8. PubMed ID: 25473746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Brenner tumor of the ovary--a clinicopathological report of 5 cases].
    Li AY; Li XL; Xing LY
    Zhonghua Zhong Liu Za Zhi; 1987 May; 9(3):218-220, 10. PubMed ID: 3447865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Brenner tumor: a clinicopathologic review.
    Balasa RW; Adcock LL; Prem KA; Dehner LP
    Obstet Gynecol; 1977 Jul; 50(1):120-8. PubMed ID: 195239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Borderline ovarian tumours: retrospective analysis of twenty-one cases.
    Saygili U; Uslu T; Erten O; Doğan E
    Eur J Gynaecol Oncol; 1998; 19(2):182-5. PubMed ID: 9611063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A histogenetic consideration of ovarian mucinous tumors based on an analysis of lesions associated with teratomas or Brenner tumors.
    Nomura K; Aizawa S
    Pathol Int; 1997 Dec; 47(12):862-5. PubMed ID: 9503468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-malignant potential epithelial tumors of the ovary: a clinicopathological study.
    Hassan E; Koumantaki Y; Stefanaki K; Matalliotakis I; Koumantakis E
    Eur J Gynaecol Oncol; 1998; 19(2):170-2. PubMed ID: 9611060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Lysine-specific demethylase 1 in human epithelial ovarian cancer.
    Chen C; Ge J; Lu Q; Ping G; Yang C; Fang X
    J Ovarian Res; 2015 May; 8():28. PubMed ID: 25956476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Miscellaneous types of surface epithelial neoplasms. The well-differentiated end of the morphologic spectrum of endometrioid, clear-cell, and Brenner tumors and mixed epithelioid tumors of low malignant potential of müllerian type.
    Kempson RL; Hendrickson MR
    Pathology (Phila); 1993; 1(2):335-65. PubMed ID: 9420923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors.
    Giurgea LN; Ungureanu C; Mihailovici MS
    Rom J Morphol Embryol; 2012; 53(4):967-73. PubMed ID: 23303020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors.
    Kondi-Pafiti A; Kairi-Vassilatou E; Iavazzo Ch; Vouza E; Mavrigiannaki P; Kleanthis Ch; Vlahodimitropoulos D; Liapis A
    Arch Gynecol Obstet; 2012 Jun; 285(6):1699-702. PubMed ID: 22198845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopathologic features observation of ovarian transitional cell tumors].
    Wang L; Dong Y; Li Q; Li H; Sun X; Zhou X; Li X
    Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):118-22. PubMed ID: 25916643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
    Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of histologic type on levels of macrophage colony-stimulating factor in liquid contents of benign ovarian tumors.
    Hayashi M; Shibazaki M; Sohma R; Inaba N
    Am J Med Sci; 2006 Oct; 332(4):181-5. PubMed ID: 17031243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial ovarian tumors in children: a retrospective analysis.
    Morowitz M; Huff D; von Allmen D
    J Pediatr Surg; 2003 Mar; 38(3):331-5; discussion 331-5. PubMed ID: 12632344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ovarian cancer in girls].
    Rzepka-Górska I; Błogowska A; Malecha J
    Ginekol Pol; 1999 May; 70(5):226-30. PubMed ID: 10462953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.